Related Experiment Video

Updated: Aug 8, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

Inhibitor economics

Jerome Teitel1

  • 1University of Toronto, Toronto, Ontario, Canada. TEITELJ@smh.toronto.on.ca

Seminars in Hematology
|May 13, 2006
PubMed

Insights

Caring for hemophilia patients with inhibitors significantly increases treatment costs due to less effective bypassing therapies and expensive immune tolerance induction. These costs can be 2.5 times higher than for patients without inhibitors.

Area of Science:

  • Hematology
  • Pharmacoeconomics

Background:

  • Hemophilia treatment primarily involves clotting factor concentrates (CFC).
  • High-titer inhibitors render CFC ineffective, necessitating bypassing agents.
  • Inhibitors substantially alter treatment costs and complexity.

Purpose of the Study:

  • To analyze the economic impact of high-titer inhibitors in hemophilia treatment.
  • To compare direct treatment costs between inhibitor and non-inhibitor hemophilia patients.

Main Methods:

  • Review of direct cost data for hemophilia patient treatment.
  • Comparison of costs associated with clotting factor concentrates versus bypassing agents.
  • Analysis of costs for immune tolerance induction protocols.

Main Results:

  • Bypassing agents are less predictable and more expensive per unit than CFC.
  • Treatment costs for hemophilia patients with inhibitors are significantly higher.
  • Immune tolerance induction protocols add substantial costs due to prolonged, frequent CFC dosing.
  • Estimated cost for inhibitor patients can be 2.5 times higher than for non-inhibitor patients.
  • Outlier patients with high treatment needs can disproportionately increase overall costs.

Conclusions:

  • High-titer inhibitors represent a major cost driver in hemophilia care.
  • Treatment strategies for inhibitor patients require careful economic consideration.
  • Cost assessments for hemophilia patients with inhibitors are less predictable due to outlier effects.

More Related Videos

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition07:42

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition

Published on: September 3, 2016

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...